Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy with myoclonic absences.

Pierre Genton1, Michelle Bureau

  • 1Centre Saint-Paul, Hôpital Henri Gastaut, Marseille, France. piergen@aol.com

CNS Drugs
|October 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Centroparietal periodic sharp-wave discharges and biphasic complexes: Novel EEG biomarkers for early diagnosis of Rasmussen encephalitis.

Epilepsy & behavior reports·2026
Same author

Charlotte Dravet: Life and contributions to epileptology.

Epilepsia·2026
Same author

History of Lennox-Gastaut Syndrome: Sixty Years of Advancements in Therapeutic Practices.

Seizure·2025
Same author

History of Lennox-Gastaut Syndrome: An electro-clinical voyage in search of an epileptic syndrome.

Seizure·2025
Same author

A multicenter Phase II randomized, placebo-controlled single-blind trial with the SV2A ligand seletracetam in photosensitive epilepsy patients.

Epilepsy & behavior : E&B·2025
Same author

Globus Pallidus Internus (GPi) Neuromodulation is Not Effective in Unverricht-Lundborg Disease to Control Myoclonia.

Movement disorders : official journal of the Movement Disorder Society·2024

Epilepsy with myoclonic absences (EMA) is a debated syndrome characterized by specific absence seizures with generalized spike-wave discharges. Diagnosis requires careful neurophysiological and video documentation to distinguish it from other epilepsy types.

Area of Science:

  • Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Epilepsy with myoclonic absences (EMA) is a debated epileptic syndrome.
  • Its defining characteristics have evolved due to changes in epilepsy management and recognition of myoclonic features in other generalized epilepsies.
  • Myoclonic absences (MA) present as typical absences with sudden onset/offset, generalized spike-wave discharges, axial hypertonia, and synchronous jerks.

Purpose of the Study:

  • To clarify the diagnostic criteria and clinical characteristics of epilepsy with myoclonic absences.
  • To differentiate MA from other absence seizures with myoclonic features.
  • To discuss the variable prognosis and therapeutic outcomes in EMA.

Main Methods:

  • Clinical observation and characterization of seizure types.

Related Experiment Videos

  • Neurophysiological recording, including electroencephalography (EEG) and electromyography (EMG).
  • Review of diagnostic challenges and differentiation from similar epilepsy syndromes.

    • Main Results:

    • MA diagnosis can be missed without video-EEG and polygraphy, despite characteristic clinical and EEG findings.
    • Distinguishing MA from other absences with myoclonic features is crucial.
    • Prognosis varies, with some patients responding well to treatments like valproic acid, ethosuximide, or lamotrigine, while others show drug resistance and potential cognitive decline.

    Conclusions:

    • EMA remains a controversial entity, requiring precise diagnostic methods for accurate identification.
    • Effective treatments exist, but drug-resistant cases may evolve into severe epilepsy syndromes like Lennox-Gastaut syndrome.
    • The presence of additional seizure types, particularly generalized tonic-clonic seizures, is associated with a less favorable outcome in EMA.